HOME >> MEDICINE >> NEWS
Study: Hospitals rated top 5 percent have mortality rates 27 percent lower

GOLDEN, Colo. (February 6, 2006) Patients checking into a hospital rated in the top five percent in the country have, on average, a 27 percent lower chance of mortality and a 14 percent lower risk of complications, according to a study released today by HealthGrades, the leading independent healthcare ratings company. The annual HealthGrades study identifies hospitals in the top five percent in the nation in terms of mortality and complication rates across 26 procedures and diagnoses, from bypass surgery to hip-replacement surgery.

The study finds that 152,966 lives could have been saved, and 21,896 complications could have been avoided, if the quality of care at all hospitals matched the level of those in the top five percent.

To name hospitals in the top five percent for clinical excellence, HealthGrades' fourth annual Hospital Quality and Clinical Excellence study analyzes nearly 39 million hospitalizations over the years 2002, 2003 and 2004 at all 5,122 of the nation's nonfederal hospitals. Those with the lowest mortality and complication rates are named Distinguished Hospitals for Clinical ExcellenceTM.

"The data in this year's study indicate a clear and profound divergence between the best hospitals and all others," said Samantha Collier, MD, HealthGrades' vice president of medical affairs. "HealthGrades applauds those hospitals that have operationalized excellence, ensuring that high-quality care is delivered not just in one or two categories of care, but across the board, from cardiac care to orthopedic surgery. But this growing 'quality chasm' is of concern to healthcare professionals and patients alike, and we urge all consumers, if possible, to do their homework before checking into a hospital."

Individuals see how their local hospitals are rated, and if they have been designated Distinguished Hospitals for Clinical Excellence, for free at http://www.healthgrades.com<
'"/>


Contact: Scott Shapiro
sshapiro@healthgrades.com
720-963-6584
HealthGrades
6-Feb-2006


Page: 1 2 3

Related medicine news :

1. Study: Directly observed HIV therapy for children is promising
2. Study: Who claims to be a pediatrician?
3. Study: Chain-owned nursing homes hurt by too much standardization
4. Study: Breast cancer in younger black women is more likely to be an aggressive variety
5. Study: Super-sizing your food takes a hidden toll on your pocketbook
6. Study: Exercise, diet may protect against colorectal cancer
7. Study: Paramedics save more lives when they dont follow the rules
8. Study: Local TV news covers health a lot, but not always well
9. Study: Exercise helps speed wound healing in older adults
10. Study: N.C. parents want tobacco use prevention to become higher priority
11. Study: No effects of type II diabetes on aggressiveness of prostate cancer; long-term survival worse

Post Your Comments:
(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: